Preliminary research indicate conolidine might inhibit distinct ion channels, decreasing neuronal excitability and restricting soreness signals. This mechanism is especially pertinent in neuropathic agony, where irregular signaling will cause persistent discomfort. Moreover, conolidine seems to influence G protein-coupled receptor (GPCR) pathways i